The IPAB has recently come up with a decision that calls into question the reasoning behind an order given by the Assistant Controller of Patents & Designs allowing a pre-grant opposition against an application for a pharmaceutical patent. Details of the case are provided below. While the merits of the patent application or the opposition posed thereto had not been discussed in this case, yet given the manner in which and the grounds on which the Assistant Controller’s decision seems...
↧